Biblio

Found 231 results
2016
W. Kim, Ryan, C. J., Zhang, L., Youngren, J., Wilton, J., Alumkal, J. J., Beer, T. M., Baertsch, R., Stuart, J., Chi, K. N., and , “Dehydroepiandrosterone (DHEA) in metastatic castration-resistant prostate cancer (mCRPC): Preliminary results from the SU2C/PCF/AACR West Coast Dream Team (WCDT).”. American Society of Clinical Oncology, 2016.
W. Kim, Ryan, C. J., Zhang, L., Youngren, J., Wilton, J., Alumkal, J. J., Beer, T. M., Baertsch, R., Stuart, J., Chi, K. N., and , “Dehydroepiandrosterone in metastatic castration-resistant prostate cancer: Preliminary results from the SU2C-PCF West Coast Dream Team (WCDT).”. American Society of Clinical Oncology, 2016.
J. D. Campbell, Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. Sekhar, Shukla, S. A., Guo, G., Brooks, A. N., Murray, B. A., and , “Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas”, Nature genetics, vol. 48, p. 607, 2016.
P. H. Waltman, Guo, J., Reistetter, E. Nahas, Purvine, S., Ansong, C. K., Van Baren, M. J., Wong, C. - H., Wei, C. - L., Smith, R. D., Callister, S. J., and , “Identifying aspects of the post-transcriptional program governing the proteome of the green alga Micromonas pusilla”, PloS one, vol. 11, p. e0155839, 2016.
S. M. Hill, Heiser, L. M., Cokelaer, T., Unger, M., Nesser, N. K., Carlin, D. E., Zhang, Y., Sokolov, A., Paull, E. O., Wong, C. K., and , “Inferring causal molecular networks: empirical assessment through a community-based effort”, Nature methods, vol. 13, p. 310, 2016.
L. R. Roberts, Farshidfar, F., Zheng, S., Gingras, M. - C., Newton, Y., Shih, J., A Robertson, G., Hinoue, T., Hoadley, K. A., Gibbs, R., and , “Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles”, in HEPATOLOGY, 2016, vol. 64, p. 227A–227A.
T. T. Liu, Achrol, A. S., Mitchell, L. A., Rodriguez, S. A., Feroze, A., Iv, M., Kim, C., Chaudhary, N., Gevaert, O., Stuart, J. M., and , “Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment”, Neuro-oncology, vol. 19, pp. 997–1007, 2016.
J. K. Lee, Phillips, J. W., Smith, B. A., Park, J. Wook, Stoyanova, T., McCaffrey, E. F., Baertsch, R., Sokolov, A., Meyerowitz, J. G., Mathis, C., and , “N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells”, Cancer cell, vol. 29, pp. 536–547, 2016.
A. Sokolov, Paull, E. O., and Stuart, J. M., “One-class detection of cell states in tumor subtypes”, in Biocomputing 2016: Proceedings of the Pacific Symposium, 2016, pp. 405–416.
A. Sokolov, Carlin, D. E., Paull, E. O., Baertsch, R., and Stuart, J. M., “Pathway-based genomics prediction using generalized elastic net”, PLoS computational biology, vol. 12, p. e1004790, 2016.
J. M. Drake, Paull, E. O., Graham, N. A., Lee, J. K., Smith, B. A., Stoyanova, T., Faltermeier, C. M., Carlin, D. E., Vashisht, A., Huang, J., and , “Patient-specific druggable networks in lethal prostate cancer through proteome-guided multi-omic integration”. American Association for Cancer Research, 2016.
R. Raj Aggarwal, Youngren, J., Sokolov, A., Huang, J., Thomas, G. V., True, L. D., Foye, A., Alumkal, J. J., Ryan, C. J., Beer, T. M., and , “Persistence of AR signaling in small cell neuroendocrine prostate cancer (SCNC) and intermediate atypical carcinoma (IAC): Results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).”. American Society of Clinical Oncology, 2016.
J. M. Drake, Paull, E. O., Graham, N. A., Lee, J. K., Smith, B. A., Titz, B., Stoyanova, T., Faltermeier, C. M., Uzunangelov, V., Carlin, D. E., and , “Phosphoproteome integration reveals patient-specific networks in prostate cancer”, Cell, vol. 166, pp. 1041–1054, 2016.
H. Si, Lu, H., Yang, X., Mattox, A., Jang, M., Bian, Y., Sano, E., Viadiu, H., Yan, B., Yau, C., and , “TNF-$\alpha$ modulates genome-wide redistribution of $Δ$Np63$\alpha$/TAp73 and NF-$ąppa$B cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer”, Oncogene, vol. 35, p. 5781, 2016.
R. Aggarwal, Beer, T. M., Gleave, M., Stuart, J. M., Rettig, M., Evans, C. P., Youngren, J., Alumkal, J. J., Huang, J., Thomas, G., and , “Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer: Update on the Stand Up 2 Cancer/Prostate Cancer Foundation–Supported West Coast Prostate Cancer Dream Team”, European urology focus, vol. 2, pp. 469–471, 2016.
M. Hafner, Niepel, M., Duan, Q., Paull, E., Stuart, J., Subramanian, A., Ma’ayan, A., and Sorger, P. K., “Transcriptional landscape of drug response guides the design of potent and synergistic drug combinations”. American Association for Cancer Research, 2016.
2015
R. Raj Aggarwal, Thomas, G., Youngren, J., Foye, A., Olson, S., Paris, P., Beer, T. M., Ryan, C. J., Witte, O., Evans, C. P., and , “Androgen receptor (AR) amplification in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) and enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WC”. American Society of Clinical Oncology, 2015.
E. Jay Small, Huang, J., Youngren, J., Sokolov, A., Aggarwal, R. Raj, Thomas, G., True, L. D., Zhang, L., Foye, A., Alumkal, J. J., and , “Characterization of neuroendocrine prostate cancer (NEPC) in patients with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) or enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer ”. American Society of Clinical Oncology, 2015.
A. D. Ewing, Houlahan, K. E., Hu, Y., Ellrott, K., Caloian, C., Yamaguchi, T. N., J Bare, C., P'ng, C., Waggott, D., Sabelnykova, V. Y., and , “Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection”, Nature methods, vol. 12, p. 623, 2015.
C. Genome Atl Network, “Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas”, New England Journal of Medicine, vol. 372, pp. 2481–2498, 2015.
E. M. Pietras, Reynaud, D., Kang, Y. - A., Carlin, D., Calero-Nieto, F. J., Leavitt, A. D., Stuart, J. M., Göttgens, B., and Passegué, E., “Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions”, Cell stem cell, vol. 17, pp. 35–46, 2015.
R. Akbani, Akdemir, K. C., B Aksoy, A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., J Auman, T., Ayala, B., and , “Genomic classification of cutaneous melanoma”, Cell, vol. 161, pp. 1681–1696, 2015.
A. Radenbaugh, “The Identification and Characterization of Alterations to DNA and RNA in Cancer Using Next-Generation Sequencing Data”, UC Santa Cruz, 2015.
C. H. A. R. L. E. S. VASKE, NG, S. A. M., PAULL, E. V. A. N., and STUART, J. O. S. H. U. A., “Integration of Cancer Omics Data into a Whole-Cell Pathway Model for Patient-Specific Interpretation”, Integrating Omics Data, p. 310, 2015.
J. Woodward, King, C., Coleman, D., Lisac, R., Schwartzman, J., Wang, N., Gleave, M., Gray, J., Thomas, G., Beer, T. M., and , “Integrative genomic analysis to identify emergent enzalutamide resistance mechanisms in castration-resistant prostate cancer”. American Association for Cancer Research, 2015.

Pages